TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
ABCL

Abcellera Biologics Inc

Healthcare · Biotechnology

11.60$ -2.8% vs. previous close Closing price · As of: Nov 12, 2026

Investor relations

Report Dates

Investor relations overview for Abcellera Biologics Inc (ABCL): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 02/23/2027.

Next report 02/23/2027
Last report 11/09/2026
Earnings surprise by quarter (%)
Q4 23 · -33.3 % 23 Q1 24 · 12.5 % 24 Q2 24 · 7.1 % 24 Q3 24 · -30.8 % 24 Q4 24 · 18.4 % 24 Q1 25 · -7.1 % 25 Q2 25 · 29.4 % 25 Q3 25 · -18.8 % 25 Q4 25 · 79.2 % 25 Q1 26 · 30.0 % 26 Q2 26 · -5.9 % 26 Q3 26 · 27.8 % 26

EPS estimate beaten

Full history 14 of 31 quarters (45%)
Last 16 quarters 9 of 16 quarters (56%)

Earnings Call Transcripts

Search all transcripts →

  • 11/09/2026 Earnings Call Q3 2026 Open →
  • 08/05/2026 Earnings Call Q2 2026 Open →
  • 05/12/2026 Earnings Call Q1 2026 Open →

News on This Stock

  • 11/09/2026 AbCellera Biologics Inc. (ABCL): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/13/2026 AbCellera Biologics Inc. (ABCL): Entry into a Material Definitive Agreement; Other Events; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?